Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
The DNA marketplace is changing: the technology is maturing, whole human genome arrays, as well as those of model organisms, are beginning to make it onto the market, and researchers have more choices of commercial platform than ever before. Diane Gershon takes a closer look at what's on offer.
Combined with the right computational tools, genomic data can uncover unknown pathways to cellular processes. Because few researchers have the resources to develop their own bioinformatics software, companies have stepped in to meet this need. Laura Bonetta reports.
The ability to trigger RNA interference in mammalian cells provides unprecedented opportunities for probing the functions of genes. Many products and resources are there to help. Laura Bonetta reports.
